Evolution Metals Projects $400 Million to $460 Million in 2027 Revenue as Magnet Output Scales (NASDAQ: EMAT)

Evolution Metals & Technologies issued fiscal 2027 revenue guidance of $400 million-$460 million, versus expected fiscal 2026 revenue of just $5 million-$8 million, contingent on ramping its expanded South Korean magnet operation. Binding orders for 13 ULVAC machines are expected to increase annual magnet capacity from roughly 1,000 metric tons to 10,000 metric tons, including 6,000 tons of high-performance sintered magnets. The expansion is supported by anticipated DFARS restrictions on China-linked rare-earth magnet supply chains beginning January 1, 2027, though the outlook is based on expected demand and prospective customer conversions rather than contracted volumes.

Analysis

The relevant read-through is not the issuer’s uncontracted revenue target, but the impending qualification bottleneck for defense-compliant NdFeB magnets. MP is best positioned among liquid U.S. exposures because its Mountain Pass-to-magnet strategy can capture both upstream NdPr pricing and downstream conversion economics; USAR has greater narrative torque but materially higher execution and financing sensitivity. The scarcity premium should accrue to qualified magnet capacity rather than simply non-China ore, creating a potential valuation separation between vertically integrated processors and upstream developers over the next 6-18 months.

The Korean manufacturing route may also make KEP an indirect beneficiary only at the margin: incremental industrial load and grid investment are unlikely to move consolidated earnings unless large power commitments become binding and tariff treatment is favorable. More important, rapid non-China capacity announcements could weaken the case for a persistent NdPr price spike, limiting upside for pure rare-earth miners while benefiting downstream OEMs and defense primes through supply security. In the next 1-3 months, the catalyst is verifiable customer offtake, third-party certification, and disclosed unit economics—not promotional capacity claims.

Consensus may be overstating the January rule as an automatic revenue conversion event. Defense programs have long procurement cycles, qualification requirements extend beyond magnet chemistry, and waiver/stockpile behavior can defer purchasing. A 10x capacity ramp also introduces equipment commissioning, feedstock consistency, yield, working-capital, and customer concentration risk; without contracted volumes, the announced revenue run-rate should receive little credit in valuation. This thesis is falsified for MP if magnet shipments or contracted offtake fail to scale by 1H27, or if NdPr realized prices compress despite policy support.

Key Decisions for Investors

• Maintain/establish a 6-12 month long MP position versus USAR as the higher-quality way to express defense-compliant magnet localization; favor a 2:1 MP/USAR dollar pair. MP has nearer-term operating proof points, while USAR is more exposed to capex, financing and qualification slippage. Reassess if MP fails to disclose incremental magnet offtake or downstream volume progress by its next two earnings reports.
• Do not underwrite EMAT-related supply-chain claims into liquid peer valuations until purchase orders, customer names, pricing, and commissioning milestones are independently disclosed. Treat any sharp sympathy rally in USAR as a trim/short-term hedge opportunity rather than confirmation of sector fundamentals.
• Watch MP quarterly magnet revenue, NdPr realizations, inventory build, and capex versus guidance through 1H27. A combination of rising magnet shipments and stable NdPr pricing supports multiple expansion; rising inventory or negative gross-margin progression would argue for reducing exposure.
• Avoid a directional KEP trade on this development alone. Set an alert for a definitive long-term power-purchase agreement and disclosed incremental rate-base treatment; absent those terms, the load-growth impact is immaterial to a utility of KEP’s scale.